Skip to main content
Acta Pharmaceutica Sinica. B logoLink to Acta Pharmaceutica Sinica. B
. 2020 Jun 29;10(8):1586–1587. doi: 10.1016/j.apsb.2020.06.010

Author correction to ‘Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors’ [Acta Pharmaceutica Sinica B 8 (2018) 200–208]

Qing Chen 1, Ke Tang 1, Xiaoyu Zhang 1, Panpan Chen 1, Ying Guo 1,
PMCID: PMC7488358  PMID: 32963952

The authors regret that there is an error in Fig. 3A“HIV/LLOV-GP (160 ng p24/mouse) 90 h.p.i.” group due to the mistake of copying and pasting in the process of assembling figures. The bioluminescence image of the second mouse in HIV/LLOV-GP-infected 90 h.p.i. group in Fig. 3A is repeated with the first mouse in the same group. As the bioluminescence values of total flux of whole body ROI in mice in Fig. 3B and C acquired from the correct mice, the revision in Fig. 3A does not affect the data calculations and any results and conclusions of the work.

The correct picture of the first and second mice in HIV/LLOV-GP-infected 90 h.p.i. group is provided, and the authors revised Fig. 3A as below.

The authors apologize for the inadvertent mistake and any inconvenience caused.

The correct picture of the first and second mice in HIV/LLOV-GP-infected 90 h.p.i. group is:

Image 1

Fig. 3A is revised as:

Image 2

Footnotes

Peer review under responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.


Articles from Acta Pharmaceutica Sinica. B are provided here courtesy of Elsevier

RESOURCES